Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Rademacher

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Rheumatology|January 17, 2016
Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18Judith Rademacher, Angela Kill, Kathrin Mattat, et al.
RMD Open|September 22, 2023
HLA-B27 status and inflammatory MRI lesions of the sacroiliac joints: a post hoc analysis in patients without axial spondyloarthritisSevtap Tugce Ulas, Fabian Proft, Torsten Diekhoff, et al.
Rheumatology (Oxford, England)|March 20, 2024
Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapyValeria Rios Rodriguez, Murat Torgutalp, Fabian Proft, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 28, 2025
The impact of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: 10-year results from an inception cohortMurat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, et al.
Rheumatology (Oxford, England)|May 9, 2022
Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritisKatharina Ziegeler, Sevtap Tugce Ulas, Denis Poddubnyy, et al.
RMD Open|December 31, 2024
Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritisJudith Rademacher, Murat Torgutalp, Christine Maria Hempel, et al.
Rheumatology (Oxford, England)|March 5, 2019
Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritisJudith Rademacher, Lorraine Madeline Tietz, Lien Le, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 19, 2022
Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception CohortMurat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, et al.
RMD Open|January 6, 2025
Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapyMurat Torgutalp, Judith Rademacher, Fabian Proft, et al.
Seminars in Arthritis and Rheumatism|February 12, 2022
Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapyJudith Rademacher, Mark Siderius, Laura Gellert, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Rheumatology|January 17, 2016
Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18Judith Rademacher, Angela Kill, Kathrin Mattat, et al.
RMD Open|September 22, 2023
HLA-B27 status and inflammatory MRI lesions of the sacroiliac joints: a post hoc analysis in patients without axial spondyloarthritisSevtap Tugce Ulas, Fabian Proft, Torsten Diekhoff, et al.
Rheumatology (Oxford, England)|March 20, 2024
Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapyValeria Rios Rodriguez, Murat Torgutalp, Fabian Proft, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 28, 2025
The impact of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: 10-year results from an inception cohortMurat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, et al.
Rheumatology (Oxford, England)|May 9, 2022
Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritisKatharina Ziegeler, Sevtap Tugce Ulas, Denis Poddubnyy, et al.
RMD Open|December 31, 2024
Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritisJudith Rademacher, Murat Torgutalp, Christine Maria Hempel, et al.
Rheumatology (Oxford, England)|March 5, 2019
Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritisJudith Rademacher, Lorraine Madeline Tietz, Lien Le, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 19, 2022
Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception CohortMurat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, et al.
RMD Open|January 6, 2025
Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapyMurat Torgutalp, Judith Rademacher, Fabian Proft, et al.
Seminars in Arthritis and Rheumatism|February 12, 2022
Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapyJudith Rademacher, Mark Siderius, Laura Gellert, et al.
Pageof 6